Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie GmbhfiledCriticalBiochemie Gmbh
Priority to AT205897ApriorityCriticalpatent/AT405402B/de
Publication of ATA205897ApublicationCriticalpatent/ATA205897A/de
Application grantedgrantedCritical
Publication of AT405402BpublicationCriticalpatent/AT405402B/de
(E)-3-(1-n-butyl-5-(2-(2-carboxyphenyl)methoxy-4-chlorophenyl)-1H-pyrazol-4-yl)-2-((5-methoxy-2,3-dihydrobenzo-furan-6-yl)methyl)-prop-2-enoic acid monoarginilyn salt
2-[4-(дифенілметіл)-1-піперазиніл]-оцтові кислоти або їх аміди, або їх нетоксичні фармацевтично прийняті солі, що проявляють спазмолітичну і антигістамінну активність
Modificacao cristalina a de acido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-¬4.3.0|nonan-8-il)-6-fluoro-1,4-di-hidro-4-oxo-3-quinolinocarboxilico